Transplant Immunology Flashcards

1
Q

What are the three types of immunological rejection? [3] xx

A

Hyperacute: minutes to hours

Acute: one to six weeks

Chronic: months to years

(Defined on basis of time to occurrence)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are two mechanisms that acute rejection occurs?

A

Acute rejection can be either via:

Acute Cellular Rejection (ACR)
- Cytotoxic T lymphocyte response
- Macrophage response

OR

Acute Antibody Mediated Response (AMR)

  • B lymphocyte response making antibodies (agaisnt MHC Class 1 /2 antigens or ABO blood group antigens)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What does these histopathological slides show?

A

CD8 Lymphocyte infiltration: even intravascular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Antibody-mediated rejection (AMR):

What are the main antigens targets of antibodies? [3]
Where does this mainly occur? [1]

A

Antibody targets:
* MHC (Class I & II): HLA antigens:
* ABO antigens
* MHC class I-related chain A (MICA)

Target location: endothelium - targets arteries and capillaries (because these are the cells first meet after transplantation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the histological features of antibody mediated rejection (AMR)?

(Don’t need to know that much)

A
  • Neutrophils (or mononuclear cells) in peritubular capillaries (microvascular inflammation)
  • Thrombosis
  • Severe arteritis/fibrinoid necrosis of vessels
  • Haemorrhage
  • Infarction
  • C4d deposition

Definitive diagnosis depends on detection of circulating antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

With regards to acute rejection of transplants, how would you detect antibody prescence?

A

Detect antibody presence with complement: C4d

  • The antibody-antigen complex activates the compliment system
  • This produces C4d molecules (which forms covalent bonds with endothelial cells)
  • C4d molecules are stained easily
  • This shows that acute rejection has occurred

Staining for C4d is a very good proxy for detecting antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Acute antibody mediated transplatn rejecton:

there is a very good correlation between high [] levels and [] antibodies.

A

there is a very good correlation between high C4d levels and donor specific antibodies.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is criteria for diagnosis of acute antibody rejection? [3]

A

Evidence of acute renal injury on histology (often microvascular inflammation)

Evidence of antibody activity C4d staining in peritubular capillaries

Circulating anti-donor specific antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Hyperacute rejection:

Explain what hyperacute rejection is mediated by? [1]

A

Hyperacute: mediated by antibodies that have been preactivated:

means that immune response has occurred before the transplant has occurred

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Explain three causes of preactivation that causes hyper acute rejection? [3]

A

Previous transplant: presence of antigen on the transplant that has already been seen on previous transplant. HLA protein common to both transplants but not seen in the recipient

Previous pregnancy: if foetal blood escapes into circulation. Paternal antigens can prime the mothers immune system

Previous blood transfuison: HLA antigen in blood, when transplant occur causes hyperacute immune response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Explain how AMR causes damage in hyperacute rejection

A

change from anti-coagulant to pro-coagulant state:

  • antibodies bind to surface of epithelial cells: become pro-coagulant and clots form
  • causes downstream infarction
  • causes haem.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Summary of hyperacute rejection:

Within 1 hr you get [] infiltrate of peritubular capillaries

Within 12-24 hrs you get what effects? [2]

A

Within 1 hr you get neutrophils infiltrate of peritubular capillaries

Within 12-24 hrs you get intravascular coagulation and cortical necrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What overriding causes of chronic rejection of transplant? [2]

A

Failure of graft to work (not true rejection)

OR

True rejection of graft

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Why may a graft fail (not true chronic rejection)? [3]

A

Damage before transplant

Surgical complications

Reoccurrence of orginal disease

(and then also rejection)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How can we prevent hyperacute rejection? [3]

A
  1. Use somone who is ABO compatabile (O is universal donor)
  2. screen for preformed antibodies:
    * Direct cross match: mix donor cells and recipient serum. Look for complement activation (positive is bad)
    * Beads with bound HLA: look to see if recipient serum binds to HLA beads
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is HLA and why is it important with transplants?

A

HLA is responsible for presenting antigens to T cell receptor

The T cell ‘sees’ the antigen sat in the groove of the HLA protein

Therefore some HLA is exposed

The T cell can therefore recognise slightly different HLA molecules from this exposed part: can be seen as non-self and T cell acts like its a pathogen and create antibodies to the HLA

17
Q

What are the most important HLAs? [3]

A

HLA A
HLA B
HLA DR

Each have two genes

18
Q

What is aim when undergoing HLA matching for transplants?

Why can you have potentially 6 HLA mismatches? [3]

A

Want to find recipient / donor with as few HLA matches as possible:

The chance of graft survival increases with fewer matches

Because have HLA A, HLA B and HLA DR have two genes - have 6 possible mismatches

19
Q

Why does number of HLA mismatches on first transplant impact second transplant?

A

If you mismatch someone with a common allele (e.g. DR4), it means that they cant have transplant from same HLA in future - which might limit their options

20
Q

Explain how can you prevent acute rejection of transplants? [2]

A

HLA matching (make sure that not positive for match)

Minimising ischaemia-reperfusion injury:

  • Ischaemia causes upregulation of adhesion molecules, which increases adhesion of leukocytes when blood is reperfused.
  • More leukocytes increases chance of rejection, SO try and limit ischaemia time.
  • Cold ischaemia time: 12 hrs
  • Warm ishaemia time: 1 hour
21
Q

How can you prevent chronic transplant rejection? [4]

A

Choosing best organ
Minimising surgical damage
Minimising acute rejection
Minimising drug-toxicity

22
Q

How does the relationship between recipient and graft evolve over lifetime of transplant? [2]

A

Initially: very aggressive because the organ is covered in donor-type APC, which are then replaced with recipient APCs

Get development of active regulation from T cell which dampen down immune response

23
Q

What are the two pathways of allorecognition?

A

Direct:
* Recipient T-cells recognise allogenic APC (donor APCs) and cause aggressive imune response to foreign HLA

Indirect:
* The allogenic APCs are replaced with auto-APCs
* Some of the peptides presented by new auto-APCS are derived from shed HLA molecules
* Causes a more gentle immune response

24
Q

Explain how activation of a helper T cell / CD4 cell occurs [3]

A
  1. T helper cell receptor recognising antigen from HLA
  2. Co-stimulation from another molecule

Both these signals activate nucleus to make IL-2.

IL-2 binds to IL-2 receptor on different T helper cell. [3]

Causes signal at nucleus to make proliferation of T-helper cells

25
Q

What are the sites of action used for immunosuppressive drugs? [3] and what drugs used?

A

Calcineurin inhibitors:
* Calcineurin is an enzyme that activates T-cells of the immune system.
* E.g. Cyclosporin and tacrolimus (learn !)

Anti-proliferative drugs:
* (target nucleus at end stage of T cell activation)
* e.g. Azathioprine and Mycophenolic acid

Prevent cytokine (IL-2) gene activation
* Use cortiosteroids
* e.g. Prednisolone

Standard treatment: Calcineurin inhib, steroid and anti-proliferative drugs